Genetic Diversity and Lack of Artemisinin Selection Signature on the Plasmodium falciparum ATP6 in the Greater Mekong Subregion

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Miao, Miao ^a   Wang, Zenglei ^a   Yang, Zhaoqing ^b   Yuan, Lili ^b   Parker, Daniel M ^a   Putaporntip, Chaturong ^c   Jongwutiwes, Somchai ^c   Xangsayarath, Phonepadith ^d   Pongvongsa, Tiengkham ^e   Moji, Hazuhiko ^f   Dinh Tuong, Trinh ^g   Abe, Tomoko ^d   Nakazawa, Shusuke ^d   Kyaw, Myat Phone ^h   Yan, Guiyun ⁱ   Sirichaisinthop, Jeeraphat ^j   Sattabongkot, Jetsumon ^k   Mu, Jianbing ^l   Su, Xin zhuan ^l   Kaneko, Osamu ^d   Cui, Liwang ^a   more..

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d NAGASAKI UNIVERSITY   (Japan)

^e Station of Malariology Parasitology and Entomology   (Laos)

^f RESEARCH INSTITUTE FOR HUMANITY AND NATURE   (Japan)

^g National Institute of Malariology Parasitology and Entomology Hanoi   (Viet Nam)

^h Department of Medical Research Lower Myanmar ^*  (Myanmar)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j Vector Borne Disease Training Center   (Thailand)

^k MAHIDOL UNIVERSITY   (Thailand)

^l NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE SEQUENCE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; MOLECULAR EVOLUTION; MUTATIONAL ANALYSIS; MUTATOR GENE; NATURAL SELECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PFATP6 GENE; PLASMODIUM FALCIPARUM; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIMALARIALS; ARTEMISININS; ASIA, SOUTHEASTERN; CALCIUM-TRANSPORTING ATPASES; DNA, PROTOZOAN; DRUG RESISTANCE; HAPLOTYPES; HUMANS; MALARIA, FALCIPARUM; MUTATION; PHYLOGEOGRAPHY; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE; SELECTION, GENETIC;

PLASMODIUM FALCIPARUM;

EID: 84875445712     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059192     Document Type: Article

References (67)

1. WHO (2010) World Malaria Report 2010. Available: http://www.who.int/malaria/world_malaria_report_2010/en/index.html. Accessed 2013 January 14.
2. Nosten F, White NJ, (2007) Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg 77: 181-192.
3. Bosman A, Mendis KN, (2007) A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies. Am J Trop Med Hyg 77: 193-197.
4. Feachem R, Sabot O, (2008) A new global malaria eradication strategy. Lancet 371: 1633-1635.
5. Mendis K, Rietveld A, Warsame M, Bosman A, Greenwood B, et al. (2009) From malaria control to eradication: The WHO perspective. Trop Med Int Health 14: 802-809.
6. Dondorp AM, Yeung S, White L, Nguon C, Day NP, et al. (2010) Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol 8: 272-280.
7. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, et al. (2008) Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359: 2619-2620.
8. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, et al. (2009) Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361: 455-467.
9. Noedl H, Se Y, Sriwichai S, Schaecher K, Teja-Isavadharm P, et al. (2010) Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Clin Infect Dis 51: e82-89.
10. Carrara VI, Zwang J, Ashley EA, Price RN, Stepniewska K, et al. (2009) Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One 4: e4551.
11. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, et al. (2002) Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418: 320-323.
12. Roper C, Pearce R, Nair S, Sharp B, Nosten F, et al. (2004) Intercontinental spread of pyrimethamine-resistant malaria. Science 305: 1124.
13. WHO (2011) Global plan for artemisinin resistance containment (GPARC) 87.
14. O'Neill PM, Barton VE, Ward SA The molecular mechanism of action of artemisinin-the debate continues. Molecules 15: 1705-1721.
15. Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, et al. (2003) Artemisinins target the SERCA of Plasmodium falciparum. Nature 424: 957-961.
16. Uhlemann AC, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, et al. (2005) A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat Struct Mol Biol 12: 628-629.
17. Valderramos SG, Scanfeld D, Uhlemann AC, Fidock DA, Krishna S, (2010) Investigations into the role of the Plasmodium falciparum SERCA (PfATP6) L263E mutation in artemisinin action and resistance. Antimicrob Agents Chemother 54: 3842-3852.
18. Jambou R, Legrand E, Niang M, Khim N, Lim P, et al. (2005) Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet 366: 1960-1963.
19. Jambou R, Martinelli A, Pinto J, Gribaldo S, Legrand E, et al. (2010) Geographic structuring of the Plasmodium falciparum sarco(endo)plasmic reticulum Ca2+ ATPase (PfSERCA) gene diversity. PLoS One 5: e9424.
20. Mugittu K, Genton B, Mshinda H, Beck HP, (2006) Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania. Malar J 5: 126.
21. Dahlstrom S, Veiga MI, Ferreira P, Martensson A, Kaneko A, et al. (2008) Diversity of the sarco/endoplasmic reticulum Ca(2+)-ATPase orthologue of Plasmodium falciparum (PfATP6). Infect Genet Evol 8: 340-345.
22. Tanabe K, Zakeri S, Palacpac NM, Afsharpad M, Randrianarivelojosia M, et al. (2011) Spontaneous mutations in the Plasmodium falciparum sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (PfATP6) gene among geographically widespread parasite populations unexposed to artemisinin-based combination therapies. Antimicrob Agents Chemother 55: 94-100.
23. Tahar R, Ringwald P, Basco LK, (2009) Molecular epidemiology of malaria in Cameroon. XXVIII. In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum and sequence analysis of the P. falciparum ATPase 6 gene. Am J Trop Med Hyg 81: 13-18.
24. Menegon M, Sannella AR, Majori G, Severini C, (2008) Detection of novel point mutations in the Plasmodium falciparum ATPase6 candidate gene for resistance to artemisinins. Parasitol Int 57: 233-235.
25. Ibrahim ML, Khim N, Adam HH, Ariey F, Duchemin JB, (2009) Polymorphism of PfATPase in Niger: detection of three new point mutations. Malar J 8: 28.
26. Bertaux L, Quang le H, Sinou V, Thanh NX, Parzy D, (2009) New PfATP6 mutations found in Plasmodium falciparum isolates from Vietnam. Antimicrob Agents Chemother 53: 4570-4571.
27. Zhang G, Guan Y, Zheng B, Wu S, Tang L, (2008) No PfATPase6 S769N mutation found in Plasmodium falciparum isolates from China. Malar J 7: 122.
28. Cojean S, Hubert V, Le Bras J, Durand R, (2006) Resistance to dihydroartemisinin. Emerg Infect Dis 12: 1798-1799.
29. Shahinas D, Lau R, Khairnar K, Hancock D, Pillai DR, (2010) Artesunate misuse and Plasmodium falciparum malaria in traveler returning from Africa. Emerg Infect Dis 16: 1608-1610.
30. Pillai DR, Lau R, Khairnar K, Lepore R, Via A, et al. (2012) Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections. Malar J 11: 131.
31. Woodrow CJ, Gardner KB, Bustamante LY, (2012) Questions over high frequency of mutant PfATP6 haplotypes in traveller isolates. Malar J 11: 186.
32. Cui L, Wang Z, Jiang H, Parker D, Wang H, et al. (2012) Lack of association of the S769N mutation in Plasmodium falciparum SERCA (PfATP6) with resistance to artemisinins. Antimicrob Agents Chemother 56: 2546-2552.
33. Cui L, Yan G, Sattabongkot J, Cao Y, Chen B, et al. (2012) Malaria in the Greater Mekong Subregion: Heterogeneity and complexity. Acta Trop 121 227-239.
34. Meng H, Zhang R, Yang H, Fan Q, Su X, et al. (2010) In vitro sensitivity of Plasmodium falciparum clinical isolates from the China-Myanmar border area to quinine and association with polymorphism in the Na+/H+ exchanger. Antimicrob Agents Chemother 54: 4306-4313.
35. Ferreira ID, Lopes D, Martinelli A, Ferreira C, do Rosario VE, et al. (2007) In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from Sao Tome and Principe. Trop Med Int Health 12: 353-362.
36. Ewing B, Green P, (1998) Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res 8: 186-194.
37. Ewing B, Hillier L, Wendl MC, Green P, (1998) Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res 8: 175-185.
38. Gordon D, Abajian C, Green P, (1998) Consed: a graphical tool for sequence finishing. Genome Res 8: 195-202.
39. Thompson JD, Higgins DG, Gibson TJ, (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
40. Librado P, Rozas J, (2009) DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 25: 1451-1452.
41. Nei M, Gojobori T, (1986) Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 3: 418-426.
42. Tamura K, Dudley J, Nei M, Kumar S, (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
43. McDonald JH, Kreitman M, (1991) Adaptive protein evolution at the Adh locus in Drosophila. Nature 351: 652-654.
44. Tajima F, (1989) Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123: 585-595.
45. Fu YX, Li WH, (1993) Statistical tests of neutrality of mutations. Genetics 133: 693-709.
46. Excoffier L, Laval G, Schneider S, (2005) Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 1: 47-50.
47. Templeton AR, Crandall KA, Sing CF, (1992) A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping and DNA sequence data. III. Cladogram estimation. Genetics 132: 619-633.
48. Castelloe J, Templeton AR, (1994) Root probabilities for intraspecific gene trees under neutral coalescent theory. Mol Phylogenet Evol 3: 102-113.
49. Posada D, Crandall KA, (1998) MODELTEST: testing the model of DNA substitution. Bioinformatics 14: 817-818.
50. Tamura K, Nei M, (1993) Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 10: 512-526.
51. Pele J, Becu J-M, Abdi H, Chabbert M (2012) bios2mds: From Biological Sequences to MultiDimensional Scaling. R package version 1.2.2. (http://CRAN.R-project.org/package=bios2mds. Accessed 2013 Jan 14).
52. Tanabe K, Sakihama N, Hattori T, Ranford-Cartwright L, Goldman I, et al. (2004) Genetic distance in housekeeping genes between Plasmodium falciparum and Plasmodium reichenowi and within P. falciparum. J Mol Evol 59: 687-694.
53. Krishna S, Pulcini S, Fatih F, Staines H, (2010) Artemisinins and the biological basis for the PfATP6/SERCA hypothesis. Trends Parasitol 26: 517-523.
54. Kwansa-Bentum B, Ayi I, Suzuki T, Otchere J, Kumagai T, et al. (2011) Plasmodium falciparum isolates from southern Ghana exhibit polymorphisms in the SERCA-type PfATPase6 though sensitive to artesunate in vitro. Malar J 10: 187.
55. Rand DM, Kann LM, (1996) Excess amino acid polymorphism in mitochondrial DNA: contrasts among genes from Drosophila, mice, and humans. Mol Biol Evol 13: 735-748.
56. Toyoshima C, Nomura H, Sugita Y, (2003) Structural basis of ion pumping by Ca(2+)-ATPase of sarcoplasmic reticulum. FEBS Lett 555: 106-110.
57. Berridge MJ, Lipp P, Bootman MD, (2000) The versatility and universality of calcium signaling. Nat Rev Mol Cell Biol 1: 11-21.
58. Volkman SK, Sabeti PC, DeCaprio D, Neafsey DE, Schaffner SF, et al. (2007) A genome-wide map of diversity in Plasmodium falciparum. Nat Genet 39: 113-119.
59. Anderson TJ, Haubold B, Williams JT, Estrada-Franco JG, Richardson L, et al. (2000) Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol Biol Evol 17: 1467-1482.
60. Jeffares DC, Pain A, Berry A, Cox AV, Stalker J, et al. (2007) Genome variation and evolution of the malaria parasite Plasmodium falciparum. Nat Genet 39: 120-125.
61. Tanabe K, Mita T, Jombart T, Eriksson A, Horibe S, et al. (2010) Plasmodium falciparum accompanied the human expansion out of Africa. Curr Biol 20: 1283-1289.
62. Tajima F, (1989) DNA polymorphism in a subdivided population: the expected number of segregating sites in the two-subpopulation model. Genetics 123: 229-240.
63. Cui L, Su XZ, (2009) Discovery, mechanisms of action and combination therapy of artemisinin. Expert Rev Anti Infect Ther 7: 999-1013.
64. Bacon DJ, McCollum AM, Griffing SM, Salas C, Soberon V, et al. (2009) Dynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria. Antimicrob Agents Chemother 53: 2042-2051.
65. Cheeseman IH, Miller BA, Nair S, Nkhoma S, Tan A, et al. (2012) A major genome region underlying artemisinin resistance in malaria. Science 336: 79-82.
66. Chavchich M, Gerena L, Peters J, Chen N, Cheng Q, et al. (2010) Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum. Antimicrob Agents Chemother 54: 2455-2464.
67. Cui L, Wang Z, Miao J, Miao M, Chandra R, et al. (2012) Mechanisms of in vitro resistance to dihydroartemisinin in Plasmodium falciparum. Mol Microbiol 86: 111-128.